1. GO-DACT: a phase 3b randomised, double-blind, placebo-controlled trial of GOlimumab plus methotrexate (MTX) versus placebo plus MTX in improving DACTylitis in MTX-naive patients with psoriatic arthritis. Issue 4 (19th March 2020) Authors: Vieira-Sousa, Elsa; Alves, Pedro; Rodrigues, Ana M; Teixeira, Filipa; Tavares-Costa, Jose; Bernardo, Alexandra; Pimenta, Sofia; Pimentel-Santos, Fernando M; Gomes, João Lagoas; Aguiar, Renata; Pinto, Patrícia; Videira, Taciana; Catita, Cristina; Santos, Helena; Borges, Joana; Sequeira, Graça; Rib... Journal: Annals of the rheumatic diseases Issue: Volume 79:Issue 4(2020) Page Start: 490 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗